Improving drug discovery using advanced computational methods.
Next generation free energy perturbation (FEP) calculations--enabled by a novel integration of quantum mechanics (QM) with molecular dynamics allowing a large QM region and no sampling compromises
['FUNDING_SBIR_2'] · QUANTUM SIMULATION TECHNOLOGIES, INC. · NIH-11007917
This study is looking at new ways to find better medications faster by using advanced computer techniques to see how well different drug-like molecules connect with their targets, which could help patients get more effective treatments sooner.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | QUANTUM SIMULATION TECHNOLOGIES, INC. (nih funded) |
| Locations | 1 site (Boston, UNITED STATES) |
| Trial ID | NIH-11007917 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing drug discovery processes by integrating quantum mechanics with molecular dynamics to improve free energy perturbation (FEP) calculations. By using advanced computational techniques, the project aims to more accurately evaluate how different drug-like molecules bind to their targets, which can significantly speed up the identification of effective drug candidates. Patients may benefit from faster development of new medications that are more effective and tailored to their conditions. The approach seeks to reduce reliance on traditional, time-consuming laboratory methods.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be individuals with conditions that require new drug therapies, particularly those related to complex diseases.
Not a fit: Patients who are not seeking new treatments or those with conditions that are already well-managed by existing therapies may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more efficient drug development, resulting in new treatments for patients.
How similar studies have performed: Previous research has shown success in using computational methods for drug discovery, but this specific integration of quantum mechanics with molecular dynamics is a novel approach.
Where this research is happening
Boston, UNITED STATES
- QUANTUM SIMULATION TECHNOLOGIES, INC. — Boston, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PEARLMAN, DAVID A — QUANTUM SIMULATION TECHNOLOGIES, INC.
- Study coordinator: PEARLMAN, DAVID A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.